Molecular Mechanisms of Action and Cytotoxicity of Platinum-Based Therapeutics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 May 2025 | Viewed by 108
Special Issue Editor
Interests: signal transduction; hormones; apoptosis; autophagy; metabolism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Platinum-based therapies, including cisplatin, carboplatin, and oxaliplatin, are widely used for the chemotherapeutic eradication of various cancers. However, their clinical application is limited by severe side effects, including systemic toxicity and drug resistance. Recent advancements in nanotechnology have introduced innovative modifications, such as platinum nanoclusters and targeted delivery systems, which aim to enhance therapeutic efficacy while simultaneously minimizing adverse effects. These approaches offer improved tumor selectivity, reduced toxicity, and potential applications in overcoming drug resistance. In addition to DNA damage, other key mechanisms of platinum drugs include ER stress, acidification of the cytoplasm, disruption of RNA transcription, inhibition of key oncogenic proteins, and a decrease in the metabolic plasticity of cancer cells, in addition to changes in their mechanobiology. Researchers continue to explore molecular mechanisms, innovative drug designs, and combination therapies to expand the therapeutic utility of platinum-based drugs. This issue explores the latest insights into the molecular mechanisms of action, cytotoxicity, and innovative approaches to improve the therapeutic index of platinum-based agents.
Dr. Antonella Muscella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- platinum-based drugs
- cancer therapy
- cisplatin
- drug resistance
- nanodrugs
- targeted delivery systems
- molecular mechanisms
- systemic toxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
